BREAST CANCER RESEARCHERS UNCOVER NEW GENETIC RISK FACTOR LINKED TO AGGRESSIVE TUMOR GROWTH
NEW YORK, NY — A groundbreaking study published today in the journal Nature Genetics has identified a novel genetic mutation that significantly increases the risk of developing aggressive forms of breast cancer. According to researchers at Columbia University, the discovery centers on a previously unknown variant of the BRCA2 gene, which affects approximately 1 in 800 women globally. The study analyzed genetic data from over 50,000 patients across 12 countries, revealing that carriers of this specific mutation have a 70 percent higher likelihood of developing triple-negative breast cancer, a subtype resistant to standard therapies. Dr. Sarah Chen, lead author of the study, stated that this finding could enable earlier screening and targeted treatment strategies for high-risk populations. The research team emphasized that further clinical trials are necessary to validate these results and integrate them into routine genetic testing protocols. This comes as breast cancer remains the most common cancer among women worldwide, with an estimated 2.3 million new cases diagnosed annually.